These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2090 related articles for article (PubMed ID: 16766368)
21. T helper cell subsets in the pathogenesis of systemic lupus erythematosus. Reininger L; Santiago ML; Takahashi S; Fossati L; Izui S Ann Med Interne (Paris); 1996; 147(7):467-71. PubMed ID: 9092356 [TBL] [Abstract][Full Text] [Related]
22. Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells. Luzina IG; Knitzer RH; Atamas SP; Gause WC; Papadimitriou JC; Sztein MB; Storrer CE; Handwerger BS Arthritis Rheum; 1999 Mar; 42(3):561-8. PubMed ID: 10088780 [TBL] [Abstract][Full Text] [Related]
23. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab. Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433 [TBL] [Abstract][Full Text] [Related]
24. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis. Sainis K; Datta SK J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184 [TBL] [Abstract][Full Text] [Related]
25. Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease. Bodolay E; Aleksza M; Antal-Szalmás P; Végh J; Szodoray P; Soltész P; Szegedi A; Szekanecz Z J Rheumatol; 2002 Oct; 29(10):2136-42. PubMed ID: 12375323 [TBL] [Abstract][Full Text] [Related]
26. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Dimitrov S; Lange T; Fehm HL; Born J Brain Behav Immun; 2004 Jul; 18(4):368-74. PubMed ID: 15157954 [TBL] [Abstract][Full Text] [Related]
27. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Shah D; Kiran R; Wanchu A; Bhatnagar A Immunol Lett; 2010 Mar; 129(1):7-12. PubMed ID: 20105444 [TBL] [Abstract][Full Text] [Related]
28. B cell apoptosis accelerates the onset of murine lupus. Trébéden-Nègre H; Weill B; Fournier C; Batteux F Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478 [TBL] [Abstract][Full Text] [Related]
29. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Mellor-Pita S; Citores MJ; Castejon R; Yebra-Bango M; Tutor-Ureta P; Rosado S; Andreu JL; Vargas JA Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277 [TBL] [Abstract][Full Text] [Related]
30. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice. Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860 [TBL] [Abstract][Full Text] [Related]
31. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Kang BY; Song YJ; Kim KM; Choe YK; Hwang SY; Kim TS Br J Pharmacol; 1999 Sep; 128(2):380-4. PubMed ID: 10510448 [TBL] [Abstract][Full Text] [Related]
32. Induction of systemic lupus erythematosus syndrome in BALB/c mice by immunization with active chromatin. Li H; Zhang YY; Sun YN; Huang XY; Jia YF; Li D Acta Pharmacol Sin; 2004 Jun; 25(6):807-11. PubMed ID: 15169636 [TBL] [Abstract][Full Text] [Related]
33. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice. Chen M; Aosai F; Norose K; Mun HS; Ishikura H; Hirose S; Piao LX; Fang H; Yano A Int Immunol; 2004 Jul; 16(7):937-46. PubMed ID: 15148287 [TBL] [Abstract][Full Text] [Related]
34. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus. Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592 [TBL] [Abstract][Full Text] [Related]
35. Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis. Simpson SJ; Holländer GA; Mizoguchi E; Allen D; Bhan AK; Wang B; Terhorst C Eur J Immunol; 1997 Jan; 27(1):17-25. PubMed ID: 9021993 [TBL] [Abstract][Full Text] [Related]
36. IL-12 producing monocytes and IFN-gamma and TNF-alpha producing T-lymphocytes are increased in placentas infected by Plasmodium falciparum. Diouf I; Fievet N; Doucouré S; Ngom M; Andrieu M; Mathieu JF; Gaye A; Thiaw OT; Deloron P J Reprod Immunol; 2007 Jun; 74(1-2):152-62. PubMed ID: 17194481 [TBL] [Abstract][Full Text] [Related]
37. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077 [TBL] [Abstract][Full Text] [Related]
38. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411 [TBL] [Abstract][Full Text] [Related]
39. Characterisation of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythaematosus. Stummvoll GH; Fritsch RD; Meyer B; Hoefler E; Aringer M; Smolen JS; Steiner G Ann Rheum Dis; 2009 Jan; 68(1):110-6. PubMed ID: 18375534 [TBL] [Abstract][Full Text] [Related]
40. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]